Invasive Fungal Infections: all 136 studies
Page 2 of 2. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.
- Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematologyCompletedNCT02127788
- Hepatosplenic CANdidiasis : PETscan and Immune Response AnalysisCompletedNCT01916057Not applicable
- Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)CompletedNCT01888458Phase 2
- Pharmacokinetics of Micafungin in Patients Intensive Care UnitCompletedNCT01783379
- Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BALCompletedNCT01576653Not applicable
- Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variatesCompletedNCT01533558
- Pharmacokinetics of Itraconazole in Pediatric Cancer PatientsCompletedNCT01409018Phase 1
- Perception and Prevalence of Fungal Infections in Berlin - BrandenburgCompletedNCT01393002
- Pre-hospital Risk Factors for Invasive Fungal InfectionStatus unknownNCT01315925
- Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) PatientsTerminatedNCT01282879Phase 4
- Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of CandidemiaStatus unknownNCT01270490Phase 3
- Caspofungin as Prophylaxis in High Risk Liver Transplantation RecipientsStatus unknownNCT01260974Phase 2
- Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal InfectionCompletedNCT01198236Phase 4
- Voriconazole Plasma Level in Intensive Care Unit (ICU) PatientsWithdrawnNCT01185405Not applicable
- Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic MalignancyTerminatedNCT01148160
- Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell TransplantationStatus unknownNCT01135589Phase 4
- A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsCompletedNCT01122368Phase 2
- A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell TransplantCompletedNCT01069887
- Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedNCT01058174Phase 3
- Anidulafungin in Patients With Hematologic MalignanciesTerminatedNCT01053884Phase 2
- Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)CompletedNCT01047267
- Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer PatientsTerminatedNCT00982540Not applicable
- Pharmacologic Optimization of VoriconazoleCompletedNCT00893555Phase 3
- Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese PatientsCompletedNCT00745992
- Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCTStatus unknownNCT00460330
- Intermittent Liposomal Amphotericin B Primary ProphylaxisStatus unknownNCT00451711Phase 2
- Prophylaxis With Caspofungin in High-Risk Liver TransplantationStatus unknownNCT00333645Phase 2
- A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal InfectionsCompletedNCT00288197Phase 4
- Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)CompletedNCT00230243
- Invasive Fungal Infections Surveillance InitiativeCompletedNCT00177944
- Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095TerminatedNCT00177749Phase 4
- Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care UnitsCompletedNCT00099775Phase 3
- Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUTerminatedNCT00048750Phase 3
- PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)CompletedNCT00034671Phase 2
- Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)CompletedNCT00034632Phase 3
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001757Phase 3